ARCHIVES

Studies Test New Agents Offering Relief From Treatment-Related Side Effects

This article is from The Cancer Letter archive.

Vol. 27 No. 7 | July 30, 2004

Download PDF Visit The Full Archive

Related Articles

Sentinel Lymph Node Excision Has No Impact on Survival

August 26, 2011

Phase II Elotuzumab Study Demonstrates 33 Months PFS

July 26, 2013

AACR Reschedules Annual Meeting For July 11-14, in Washington, DC

April 25, 2003

Smokers’ Quitlines Work, California Study Finds

October 25, 2002

FDA Urges Lower Target for ESA Use; Market Could Drop By More Than Half.

March 16, 2007

Under A Flat Budget, NIH Suspends Grant Increases, May restore Funds Later.

November 24, 2000